Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy
暂无分享,去创建一个
Robert W. Mills | P. Ellinor | S. Lubitz | Honghuang Lin | M. Lindsay | J. Stone | D. Milan | N. Tucker | Victoria A. Parsons | Micheal A McLellan | I. Domian | E. Dolmatova | Marisa A. Shea | S. Clauss | N. Scott | Jiangchuan Ye | Dongjian Hu | Honghuang Lin
[1] B. Candemir,et al. Leukocyte TRP channel gene expressions in patients with non-valvular atrial fibrillation , 2017, Scientific Reports.
[2] V. Álvarez,et al. Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients , 2017, Circulation. Cardiovascular genetics.
[3] L. Calò,et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.
[4] P. Ellinor,et al. A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. , 2016, American journal of human genetics.
[5] J. Seidman,et al. Single-Cell Resolution of Temporal Gene Expression during Heart Development. , 2016, Developmental cell.
[6] X. Puente,et al. Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C , 2016, European Journal of Human Genetics.
[7] Kenneth L. Jones,et al. FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy , 2016, JACC. Basic to translational science.
[8] J. Schwartzentruber,et al. Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human Mutation.
[9] Eduardo Kausel,et al. Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes , 2015, Stem cell reports.
[10] J. Towbin,et al. Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy. , 2014, Journal of the American College of Cardiology.
[11] X. Puente,et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.
[12] M. Marino,et al. BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS , 2014, Genetics in Medicine.
[13] Izuho Hatada,et al. Genome engineering using the CRISPR/Cas system , 2014 .
[14] Paul M. K. Gordon,et al. Titin mutation in familial restrictive cardiomyopathy. , 2014, International journal of cardiology.
[15] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[16] Michael J Ackerman,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[17] Robert H. Brown,et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. , 2011, American journal of human genetics.
[18] M. Ramsby,et al. Differential detergent fractionation of eukaryotic cells. , 2011, Cold Spring Harbor protocols.
[19] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[20] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[21] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[22] I. Ferrer,et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy , 2009, European Journal of Human Genetics.
[23] J. Hartwig,et al. Filamins in cell signaling, transcription and organ development. , 2010, Trends in cell biology.
[24] Margaret L. Karst,et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology , 2008, Clinical genetics.
[25] N. Sebire,et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes , 2008, Heart.
[26] M. Simoons,et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. , 2007, European heart journal.
[27] M. Vorgerd,et al. The pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a protein aggregation myopathy. , 2007, Human molecular genetics.
[28] Luis Vidali,et al. Filamin A (FLNA) is required for cell–cell contact in vascular development and cardiac morphogenesis , 2006, Proceedings of the National Academy of Sciences.
[29] L. Kunkel,et al. Loss of FilaminC (FLNc) Results in Severe Defects in Myogenesis and Myotube Structure , 2006, Molecular and Cellular Biology.
[30] S. Cross,et al. Cardiac malformations and midline skeletal defects in mice lacking filamin A. , 2006, Human molecular genetics.
[31] Stefan Eulitz,et al. Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP. , 2006, Experimental cell research.
[32] Hanns Lochmüller,et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.
[33] N. Laing,et al. A new dominant distal myopathy affecting posterior leg and anterior upper limb muscles , 2005, Neurology.
[34] G. Blanco,et al. Filamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibres. , 2004, Human molecular genetics.
[35] P. Elliott,et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.
[36] A. Goette,et al. Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation , 2002, Circulation.
[37] S. Kempa,et al. Indications for a Novel Muscular Dystrophy Pathway , 2000, The Journal of cell biology.
[38] Simon C Watkins,et al. Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein , 2000 .
[39] J. Nagle,et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy , 1998, Nature Genetics.
[40] K. Pollard,et al. Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.
[41] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[42] Claude-Alain H. Roten,et al. Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..
[43] J. Beckmann,et al. Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. , 2003, Muscle & nerve.